Jonathan has been Ergomed’s Chief Financial Officer since February 2023
Jonathan joined Ergomed as Deputy Chief Financial Officer in November 2022, bringing with him extensive life sciences industry experience, having spent 13 years with ICON plc, a leading global CRO business listed on NASDAQ with a market capitalisation of $19 billion.
Most recently, he was the Senior Vice President of Corporate and Commercial Finance, where he had a broad range of responsibilities including financial reporting, acquisitions and post-acquisition integration, debt and equity fundraising, treasury, commercial finance and overall financial management.
During his time with ICON, he also led the Investor Relations function and played a key role in transactions worth over $13.5 billion including most recently the $12 billion acquisition by ICON of PRA Health Sciences Inc. Jonathan is a Fellow of the Institute of Chartered Accountants with over 20 years’ experience since receiving his ACA qualification at KPMG.
